2 withdrawn. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Withdrawn 2 |
Follow ASD: new trials by email Literature Review of ASD trials Research Report on ASD
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of JZP541 in Adults With Irritability Associated With Autism Spectrum Disorder JZP541, Placebo - Irritability Associated With Autism Spectrum Disorder, Autism Spectrum Disorder | Phase 2 | Withdrawn | Jazz Pharmaceuticals | 2023-06-30 | 2024-11-08 | |
| Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Autism Spectrum Disorder and Associated GI Symptoms (SPROUT) CP101, Placebo - Autism Spectrum Disorder, Autism | Phase 2 | Withdrawn | Finch Research and Development LLC. | 2020-05-01 | 2021-04-08 |
Autism Spectrum Disorder (2) · Autistic Disorder (1) · Child Development Disorders, Pervasive (1)
Mental Disorders (2) · Neurodevelopmental Disorders (2) · Child Development Disorders, Pervasive (1)
Finch Research and Development LLC. (1) · Jazz Pharmaceuticals (1)
United States (1)